United States · Markets & Finance · Yahoo Finance

Regeneron and Sanofi Expand Global Alliance with Multiple Next-Generation, Long-Acting Immunology Antibodies

Published by Yahoo Finance · United States 10 h ago

REGN20423, a clinical-stage long-acting IL-13 monoclonal antibody invented and developed by Regeneron, is added to the alliance, along with a long-acting IL-4xIL-13 bispecific and…

Read the full article on Yahoo Finance Sign in to save

MediaNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (finance.yahoo.com)

Also worth reading

Seeking Alpha

Regeneron drug said to cut muscle loss when combined with Novo's semaglutide

Cointelegraph

Bitcoin think tank questions MSCI’s ‘invisible committee’ over Strategy, Metaplanet rule

CNBC

South Korean President Lee pushes back on Alaska LNG project after Trump touts Seoul's participation

OilPrice.com

Brent Tumbles to $96 as Gulf Oil Flows Bounce Back

CoinDesk

Dogecoin gets DeFi testnet as DogeOS bets miners will eventually secure its apps

Business Insider